An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

If you’ve ever done maintenance or repair work on your bicycle, you’ll know that positioning a bike in your workshop isn’t trivial. You can use your bike’s kickstand, or lean it against a wall, but ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Joshua Lyon Joshua Lyon is a writer covering home and decor. He requires nine ...

See Statistics Help for definitions of terms used.

Check and improve your grammar with our basic grammar reference guide. On this page you'll find links to our basic grammar summary pages. Each basic grammar reference page covers a key grammar point ...